Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia

Clinical trial NCT04659525 · UNKNOWN

Trial details

NCT number: NCT04659525
Sponsor: Policlinico Casilino ASL RMB
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hypercholesterolemia CKD Stage 5 Chronic Kidney Disease Requiring Chronic Dialysis

Start date: 2020-11-01
Primary completion: 2021-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.